Canine influenza, also known as dog flu, is a contagious respiratory disease caused by an influenza A virus that infects dogs. While non-life-threatening for most dogs, the disease is highly contagious and can cause serious illness in young, old or weak dogs. Canine influenza vaccine helps prevent the highly contagious respiratory infection in dogs. Growing adoption of pets worldwide coupled with increasing awareness about pet health management is driving the demand for canine influenza vaccine. The Global canine influenza vaccine market is expected to grow at the highest pace owing to the increasing pet adoption in Asia Pacific region.
The Global Canine Influenza Vaccine Market is estimated to be valued at US$ 1,805.7 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global canine influenza vaccine market are Zoetis Services LLC, Merck Co., Inc., Covetrus, CSL Limited, Boehringer Ingelheim Animal Health USA Inc., and Elanco.
The growing demand for dogs as companion animals worldwide is driving the canine influenza vaccine market. According to the American Pet Products Association (APPA), around 85 million pet dogs were owned in the US in 2021 and around 23% of US households own dogs.
Technological advancements in vaccine production such as recombinant DNA technology and cell culture techniques have resulted in the development of more effective and safer Canine Influenza Vaccine Market Size. Key players are focusing on development of quadrivalent vaccines that provide protection against two influenza A virus subtypes (H3N2 and H3N8).

Market Trends
Growing Focus on Preventive Healthcare: Increasing awareness about pet health is resulting in growing popularity of preventive healthcare. Canine influenza vaccination as part of preventive healthcare program is a major trend in the market.
Advent of Recombinant Vaccines: Technological advancements have led to the development of recombinant DNA vaccines that do not require virus isolation and culture. Such second-generation vaccines are safer, more effective, and scalable.

Market Opportunities
Asia Pacific Region to Drive Future Growth: Asia Pacific region, especially China and India, are expected to offer significant opportunities owing to growing pet ownership in the region. Key players are focusing on expanding their presence in Asia Pacific through collaborations.
Increasing Demand for Universal Vaccines: There is increasing demand for universal influenza vaccines that provide cross-protection against multiple subtypes. Development of such universal vaccines presents major opportunities.

Impact of COVID-19 on Global Canine Influenza Vaccine Market Growth

The COVID-19 pandemic has significantly impacted the growth of global canine influenza vaccine market. During the initial lockdown phases in 2020, veterinary practices were closed or had limited operations due to social distancing norms. This impacted the routine pet vaccination programs globally. As a result, the demand and sales of canine influenza vaccine reduced significantly during this period.

However, as the restrictions eased in late 2020, veterinary practices resumed their normal operations with appropriate safety measures. This helped revive the demand for canine influenza vaccination from pet owners. Furthermore, many people adopted pets during the lockdowns for companionship. This rising pet population base strengthened the post-pandemic sales of canine influenza vaccine.

Going forward, vaccine manufacturers are focusing on strengthening their supply chains and distribution networks to ensure continuity of supplies. They are also educating veterinarians and pet owners about the importance of routine pet vaccinations. This will help drive the growth of canine influenza vaccine market in the forecast period despite challenges posed by the pandemic. The market is expected to grow at a steady rate going ahead.

Geographical Regions with High Concentration of Global Canine Influenza Vaccine Market in Terms of Value

North America accounts for the largest share of global canine influenza vaccine market in terms of value. This is attributed to factors like high pet ownership, growing awareness about pet health, and routine vaccination culture in countries like the US and Canada. Europe is the second largest region owing to similar trends.

Asia Pacific is considered the fastest growing region for canine influenza vaccine market. This is because of rising pet adoption, increasing pet healthcare expenditure, and growing initiatives by public and private players to promote animal welfare in countries like India and China. The economic growth and urbanization in Asia is supporting the regional market expansion.
Get More Insights On Global Canine Influenza Vaccine Market